Analysts Are Bullish on Top Healthcare Stocks: Insmed (INSM), Sanara MedTech (SMTI)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insmed (INSM – Research Report) and Sanara MedTech (SMTI – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Insmed (INSM)
Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Insmed today. The company’s shares closed last Monday at $159.59.
According to TipRanks.com, Suvannavejh is a 5-star analyst with an average return of
Insmed has an analyst consensus of Strong Buy, with a price target consensus of $220.07, representing a 42.3% upside. In a report issued on January 12, Truist Financial also maintained a Buy rating on the stock.
See today’s best-performing stocks on TipRanks >>
Sanara MedTech (SMTI)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Sanara MedTech today and set a price target of $36.00. The company’s shares closed last Monday at $21.32.
According to TipRanks.com, Chen is a 3-star analyst with an average return of
Sanara MedTech has an analyst consensus of Moderate Buy, with a price target consensus of $36.00.
